DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Continued Examination Under 37 CFR 1.114
A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 08/05/26 has been entered.
Response to Amendment
The amendment filed 07/01/26 has been entered. Claim 1 has been amended. Claims 2-17 are in the original/ previously presented form. Claim 18 is newly presented. Thus, claims 1-18 remain pending in the application. Applicant’s amendments to the Specification have overcome each and every objection previously set forth in the Final Office Action mailed 05/08/26.
Claim Objections
Claims 1 and 3 are objected to because of the following informalities:
Claim 1: The last clause of claim 1 reads “wherein a width of the reduced thickness portion is less than a width of the rest of the needle cover.” and should likely read “wherein a width of the reduced thickness portion is less than a width of [[the]] a rest of the needle cover.” to provide proper antecedent basis for “rest” of the needle cover, which has not yet been recited in claim 1
Claim 3 lines 2-3 reads “…a rest of the needle cover.” And should likely read “…[[a]] the rest of the needle cover.” Because “rest” of the needle cover was already introduced in claim 1 from which claim 3 depends.
Appropriate correction is required.
Applicant is advised that should claim 3 be found allowable, claim 18 will be objected to under 37 CFR 1.75 as being a substantial duplicate thereof. When two claims in an application are duplicates or else are so close in content that they both cover the same thing, despite a slight difference in wording, it is proper after allowing one claim to object to the other as being a substantial duplicate of the allowed claim. See MPEP § 608.01(m).
Claim Interpretation
The following is a quotation of 35 U.S.C. 112(f):
(f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof.
The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph:
An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof.
The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked.
As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph:
(A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function;
(B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and
(C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function.
Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function.
Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function.
Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action.
Regarding claim 6, lines 2-3 recite “the radial protrusion has reinforcing means configured to reinforce a proximal side of this radial protrusion”. Therefore, claim 6 is interpreted under 112(f) according to the 3-prong test:
Prong 1: means is recited
Prong 2: functional language—configured to reinforce a proximal side of the radial protrusion
Prong 3: not modified by other structural language in the claims—no structure is recited for how the means configured to reinforce a proximal side of the radial protrusion reinforces the radial protrusion. Only the desired outcome of “reinforce” is recited.
According to Applicant’s disclosure under 112(f), the “means” configured to reinforce a proximal side of the radial protrusion is interpreted as a “bulge” or equivalent (bulge 410, see FIG. 4A and [0072]: the reinforcing means include a bulge).
This application includes one or more claim limitations that do not use the word “means,” but are nonetheless being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, because the claim limitation(s) uses a generic placeholder that is coupled with functional language without reciting sufficient structure to perform the recited function and the generic placeholder is not preceded by a structural modifier. Such claim limitation(s) is/are:
Claim 1 line 8: “a release element configured to move the needle cover”. Therefore, claim 1 is interpreted under 112(f) according to the 3-prong test.
Prong 1: means or generic placeholder is recited—“a release element” is considered a generic placeholder for “means” because “a release element” has no specific structural meaning
Prong 2: functional language—configured to move the needle cover
Prong 3: not modified by other structural language in the claims—no structure is recited for how the release element moves the needle cover. Only the desired outcome of “move” is recited.
According to Applicant’s disclosure under 112(f), the “a release element” configured to move the needle cover is interpreted as a spring or equivalent (spring 6, see FIG. 16A and [0064]: a release element 6 such as a spring).
Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification as performing the claimed function, and equivalents thereof.
If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph.
Claim Rejections - 35 USC § 102
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
(a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention.
Claims 1, 3-6, 8, 11, 13-14, 16, and 18 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Jansen et al. (U.S. Patent No. 6,319,233), hereinafter Jansen.
Regarding claim 1, Jansen discloses a safety device (14, see FIG-1 and col. 3 lines 60-63: a medical device 10 comprising a syringe 12==medical container and shield system 14.) for mounting onto a medical container (syringe 12, see mounted position of safety device onto the medical container in FIG-2) provided with a flange (24) and an injection needle (18, see col. 3 line 64- col. 4 line 14: syringe includes flange 24 and needle 18), the safety device (14, see ‘Modified FIG-1 below’ and col 4 lines 14-20: shield system 14 includes holder 26== a tubular body, shield 28==a needle cover, and a fitting 32== a retainer engaging a spring 30 ==a release element)
PNG
media_image1.png
560
869
media_image1.png
Greyscale
comprising:
a tubular body (26) extending along a longitudinal axis (see longitudinal axis extending horizontally through center of needle 18 in FIG-2), the tubular body (26) being configured to receive (as seen in FIG-2 and see col. 3 line 60-col.4 line 13 & col. 6 lines 23-31: system is designed to receive a syringe) the medical container (12),
a needle cover (28) movable relative to (see col. 6 lines 3-6: needle cover 28 slidably mounted==movable within holder 26) the tubular body (26) between a retracted position (see FIG-3), and an extended position (see FIG-4) in which the needle cover (28) distally extends from (see distal position of needle cover 28 in FIG-4 compared to Fig-3) the retracted position (as shown in FIG-3) in order to shield the injection needle (18) after activation of the safety device (see col. 6 lines 40-65: needle cover 28 slides axially to position as shown in at least FIG. 4 after a user applies distal force to fitting that displaces the end fitting==after activation of the safety device, aligning with Applicant disclosure of device activation as in at least [0007]),
a release element (30) configured to move the needle cover (28, see col. 6 lines 54-65: spring 30 expands causing shield 28 to slide axially) from the retracted (as shown in FIG-3) to the extended position (as shown in FIG.-4) after activation of the safety device (see col. 6 lines 40-65: spring expands after user applies distal force to fitting==after activation of safety device),
a retainer (32), the retainer (32) being configured to transmit a user's activation force to the needle cover (28) once the injection operation is completed (see col. 6 lines 40-65: following removal of needle from patient==once injection operation is completed, a user applies distal force on fitting==retainer 32, which subsequently releases the spring to move the needle cover. Therefore, the retainer 32 is ‘configured to’ transmit a user’s activation force to the needle cover by way of the spring release.), wherein
the needle cover (28) comprises a distal abutment surface (distal face of 58 marked by black solid line, see ‘Modified FIG-3’ below),
PNG
media_image2.png
500
729
media_image2.png
Greyscale
the distal abutment surface (distal face of 58) abutting against a proximal abutment surface (proximal face of 48 marked by solid gray line, see ‘Modified FIG-3’ above, proximal face of 48 marked in ‘Modified FIG-3’ above on ‘lower’ portion of bump 48, but the same proximal face of 48 exists on the ‘upper’ bump where the distal face of 58 is lined in black. Distal abutment surface an proximal abutment surfaces labeled on opposing structures for visual clarity, but the surfaces do both “abut” against one another in each of the lower and upper combinations) of a bump (48) protruding from the tubular body (26) in the retracted position (see ‘Modified FIG-3’ above) of the needle cover (28), and wherein the distal abutment surface (distal face of 58, see ‘Modified FIG-3’ above) is located on a reduced thickness portion (see reduced thickness portion, marked in gray for visual clarity, in ‘Modified FIG-4i’ below. reduced thickness portion is a smaller thickness than at least the region of the needle cover comprising structure 62, see col 5 lines 12-22) of a lateral wall (reduced thickness portion as shown in ‘Modified FIG-4i’ on side/lateral wall of needle cover) of the needle cover (28);
PNG
media_image3.png
470
692
media_image3.png
Greyscale
Wherein a width (the distance of the cross-section of the needle cover wall as measured between the outer wall and inner facing wall—as shown by the “thickness” of the reduced thickness portion in ‘Modified FIG-4i’ above in gray above) of the reduced thickness portion is less than a width (the distance of the cross-section of the needle cover wall as measured between the outer wall and inner facing wall—as shown by the “thickness” of the needle cover in ‘Modified FIG-4i’ above in black above) of the rest of the needle cover (see ‘Modified FIG.-4i’ above).
Regarding claim 3, Jansen discloses the safety device of claim 1, and Jansen further discloses wherein the reduced thickness portion has an inner diameter (from internal wall to internal wall, see ‘Modified FIG-4: claim 3’ below)
PNG
media_image4.png
442
692
media_image4.png
Greyscale
which is greater than an inner diameter of a rest (from internal wall to internal wall, see ‘Modified FIG-4: claim 3’ above) of the needle cover (see ‘Modified FIG-4: claim 3’ above).
Regarding claim 4, Jansen discloses the safety device of claim 1, and Jansen further discloses wherein the reduced thickness portion (see ‘Modified FIG.-4i’ above) is at a distal portion (a distal portion is the length of the needle cover located distally of the proximal edge of the distal abutment surface 58) of the needle cover (28).
Regarding claim 5, Jansen discloses the safety device of claim 1, and Jansen further discloses wherein at least one of the proximal abutment surface (proximal face of bump 48, see ‘Modified FIG-3’ above) and the distal abutment surface (distal face of 58, see ‘Modified FIG-3’ above) comprises a chamfer (see col. 5 lines 15-19: 48 and 58 comprise inclined surfaces==a chamfer which is a slanted edge) configured to ease passage of the needle cover (28, see col. 6 lines 49-51: inclined surfaces of 48/58 slide past each other and therefore are ‘configured to ease passage’ of the needle cover) over the bump (48) when the needle cover (48) moves distally to the extended position (as seen in FIG-4).
Regarding claim 6, Jansen discloses the safety device of claim 1, and Jansen further discloses wherein the distal abutment surface (distal face of 58, see ‘Modified FIG-3’ above) of the needle cover (28) is located on a radial protrusion (58, see FIG-1 and see col. 5 lines 15-17: 58 is a radially outwardly extending collar==radial protrusion) of the needle cover (28), and the radial protrusion (58) has reinforcing means configured to reinforce (see col. 5 lines 15-19: 58 comprises an inclined surface and therefore reasonably comprises a ‘bulge’ as interpreted under 112f above) a proximal side (proximal face of 58) of the radial protrusion (58).
Regarding claim 8, Jansen discloses the safety device of claim 1, and Jansen further discloses wherein the body (30) has a first axial slot (46A) and a second axial slot (46B, see col. 4 lines 45-62: openings 46A, B formed in holder body in opposing relation), the first axial slot (46A) and the second axial slot (46B) extending on both sides (46A on a ‘left’ side and 46B on a ‘right’ side of the bump relative to the longitudinal axis, see ‘Modified FIG-1’ below. Therefore, the slots extend on “both” sides. Further see col. 4 lines 57-62: 46A/B “interrupt” the bump) of the bump (48).
PNG
media_image5.png
521
680
media_image5.png
Greyscale
Regarding claim 11, Jansen discloses the safety device of claim 1, and Jansen further discloses wherein the bump (48, see FIG-1) of the body (26) has a first end (see proximal abutment surface/ first end as shown in ‘Modified FIG-3’ above) provided with a chamfer (see col. 5 lines 15-19: 48 and 58 comprise inclined surfaces==a chamfer which is a slanted edge) extending in a circumferential direction (48 extends circumferentially and therefore the chamfer extends in a circumferential direction along structure of bump 48).
Regarding claim 13, Jansen discloses the safety device of claim 1, and Jansen further discloses wherein the bump (48, see Fig-1) of the device includes two bumps (see ‘upper bump’==first bump traced in black and ‘lower bump’==second bump traced in gray of ‘Modified Fig-1v’ above).
Regarding claim 14, Jansen discloses the safety device of claim 1, and Jansen further discloses wherein the bump (48) has a first end (“right” side/ proximal end in ‘Modified FIG-3’ above) and an opposite second end (“left” side/ distal end in ‘Modified FIG-3’ above), and the proximal abutment surface (proximal face of bump 48, see ‘Modified FIG-3’ above) of the bump (48) has a ramp portion (inclined surface outlined in gray in ‘Modified FIG-3’ above and see col. 5 lines 15-19: 48 comprises an inclined surface==a ramp as seen by outline of proximal abutment surface in ‘Modified FIG-3’ above), the ramp portion (inclined surface) having a decreasing slope (surface inclined in direction toward proximal/ first end and therefore has a ‘decreasing’/ negative slope due to a negative change in ‘height’ of the inclined surface) towards the first end (proximal end) of the bump (48).
Regarding claim 16, Jansen discloses an injection device (10, see FIG-1) comprising a medical container (12) having an injection needle (18) and the safety device (14) of claim 1, the safety device (14) being mounted onto the medical container (12, as seen in Fig-2 and described in at least see col. 3 line 60-col.4 line 13 and col. 6 lines 23-31).
Regarding claim 18, Jansen discloses the safety device of claim 1, and Jansen further discloses wherein the reduced thickness portion includes an inner diameter (from internal wall to internal wall, see ‘Modified FIG-4: claim 18’ below)
PNG
media_image6.png
451
692
media_image6.png
Greyscale
that is greater than an inner diameter of a rest (from internal wall to internal wall, see ‘Modified FIG-4: claim 18’ above) of the needle cover (see ‘Modified FIG-4: claim 18’ above).
Claim Rejections - 35 USC § 103
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows:
1. Determining the scope and contents of the prior art.
2. Ascertaining the differences between the prior art and the claims at issue.
3. Resolving the level of ordinary skill in the pertinent art.
4. Considering objective evidence present in the application indicating obviousness or nonobviousness.
Claims 2, 9, 15, and 17 are rejected under 35 U.S.C. 103 as being unpatentable over Jansen as applied to claim 1 above, and further in view of Brunel (U.S. Patent No. 5,855,839).
Regarding claim 2, Jansen discloses the safety device of claim 1, but Jansen is silent to “wherein the reduced thickness portion comprises one or several axial grooves.”
However, Brunel teaches a safety device comprising a tubular sleeve (121, see FIG. 12a) with a reduced thickness portion (124, see col. 10 lines 47-55: weakness zones 124 can be a “decreasing cross-section” or “lines of less thickness”), the tubular sleeve (121) housing a syringe (114, see Fig. 13a and col. 10 lines 60-62) and being surrounded by a tubular sheath (109, see col. 10 lines 41-67), and wherein the reduced thickness portion (124) comprises one or several axial grooves (see col. 10 lines 47-55: lines of less thickness around the cross section==grooves).
Therefore, it would have been prima facie obvious for one of ordinary skill in the art before the effective filing date of the claimed invention to modify the reduced thickness portion of the tubular sleeve needle cover disclosed in Jansen to comprise one or several axial grooves as taught by Brunel for the purpose of allowing the tubular sleeve comprising the reduced thickness portion to be fitted easily within the surrounding sheath (see col. 10 lines 50-65), which is advantageous to Jansen’s reduced thickness portion on a needle cover/tubular sleeve 28 housing a syringe 12 and being surrounded by a tubular sheath 26, thus achieving “wherein the reduced thickness portion comprises one or several axial grooves.”
Regarding claim 9, Jansen discloses the safety device of claim 1, and Jansen further discloses wherein the body (26, see FIG-1) has a first axial slot (46A) extending from an end (end formed by finger flange 38) of the body (26), and the bump (48) is circumferentially distant (see col 4 lines 57-62: bump 48 ‘interrupted’ by slot 46A and see FIG-1—bump does not extend into slots 46A/B and therefore the slots must be ‘circumferentially distant’ or separated by a circumference) from the first axial slot (46A).
Jansen is silent to the first axial slot extending from a “distal” end of the body.
However, Brunel teaches a safety device with a body (101, see Fig. 10) comprising a first axial slot (102, see col. 8 lines 56-59) extending from a distal end (see slot extending all the way through distal end/ upward direction in FIG. 10) of the body (101).
Therefore, it would have been prima facie obvious for one of ordinary skill in the art before the effective filing date of the claimed invention to place the first axial slot on the body disclosed in Jansen at the distal end of the body as taught by Brunel for the purpose of providing the distal end of the device with a desired radial flexibility (see Brunel Figs 10-11, col. 9 lines 64-col. 10 line 27), which would be advantageous to Jansen because radial flexibility at the distal end of the body would aid in the assembly of the device when the syringe is inserted from a proximal end of the tubular body (see col 6 lines 23-24: safety system receives syringe at second end and see col. 4 lines 21-29: second open end of the holder has the flange and thus the second open end==proximal end), thus achieving the first axial slot extending from a “distal” end of the body.
Further, a person of ordinary skill in the art would have been motivated to make this modification because it is a simple substitution of one known element (a slot provided at a proximal end of a safety device as disclosed in Jansen) for another known element (a slot provided at a distal end of a safety device taught by Brunel) in the art to obtain the predictable result of providing a degree of flexibility to a chosen end of a safety device (see MPEP § 2143.I.B).
Regarding claim 15, Jansen discloses the safety device of claim 1, and Jansen further discloses wherein the body (26, see FIG-1) has a first axial slot (46A) extending from an end (end formed by finger flange 38) of the body (26), and the first axial slot (46A) having a predetermined length (see col. 4 lines 51-52: size of slot selected==has a predetermined length for amount of desired flexibility).
Jansen, in the embodiment of FIG.1, is silent to the first axial slot extending from a “distal” end of said body and the first axial slot having a predetermined length “comprised between 1 mm - 6 mm.”
However, Jansen teaches that the size of the axial slots will change the amount of flexibility of the tubular body (see col.4 lines 45-56: “The sizes of the openings are selected based upon the amount of flexibility desired in the holder body”). Therefore, a person of ordinary skill in the art would consider the flexibility of the tubular body to be a result effect variable that is optimized through routine experimentation of changing/modifying the size of the slot, such as the length, to obtain a desired flexibility of the tubular body.
Therefore, it would have been obvious to one having ordinary skill in the art at the time of the invention to modify the first axial slot disclosed in Jansen FIG.1 by selecting the predetermined length of the slot to be between 1 and 6mm to obtain a desired flexibility of the tubular body as a matter of routine optimization since it has been held that “where the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation." In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955), thus achieving wherein the first axial slot has a predetermined length “comprised between 1 mm - 6 mm.”
Jansen remains silent to the first axial slot extending from a “distal” end of said body.
However, Brunel teaches a safety device with a body (101, see Fig. 10) comprising a first axial slot (102, see col. 8 lines 56-59) extending from a distal end (see slot extending all the way through distal end/ upward direction in FIG. 10) of the body (101).
Therefore, it would have been prima facie obvious for one of ordinary skill in the art before the effective filing date of the claimed invention to place the first axial slot on the body disclosed in Jansen at the distal end of the body as taught by Brunel for the purpose of providing the distal end of the device with a desired radial flexibility (see Brunel Figs 10-11, col. 9 lines 64-col. 10 line 27), which would be advantageous to Jansen because radial flexibility at the distal end of the body would aid in the assembly of the device when the syringe is inserted from a proximal end of the tubular body (see col 6 lines 23-24: safety system receives syringe at second end and see col. 4 lines 21-29: second open end of the holder has the flange and thus the second open end==proximal end), thus achieving the first axial slot extending from a “distal” end of the body.
Further, a person of ordinary skill in the art would have been motivated to make this modification because it is a simple substitution of one known element (a slot provided at a proximal end of a safety device as disclosed in Jansen) for another known element (a slot provided at a distal end of a safety device taught by Brunel) in the art to obtain the predictable result of providing a degree of flexibility to a chosen end of a safety device (see MPEP § 2143.I.B).
Regarding claim 17, the modified system of Jansen teaches the safety device of claim 2, and Jansen further discloses wherein the reduced thickness portion (see ‘Modified FIG. 4’ above) being located on an inner side of the lateral wall (reduced thickness portion is a smaller thickness at the inner side when compared to thicker region 62 that protrudes from the inner side of the lateral wall) of the needle cover (28).
Jansen is silent to “the one of several axial grooves” of the reduced thickness portion.
However, Brunel teaches a safety device comprising a tubular sleeve (121, see FIG. 12a) with a reduced thickness portion (124, see col. 10 lines 47-55: weakness zones 124 can be a “decreasing cross-section” or “lines of less thickness”), the tubular sleeve (121) housing a syringe (114, see Fig. 13a and col. 10 lines 60-62) and being surrounded by a tubular sheath (109, see col. 10 lines 41-67), and wherein the reduced thickness portion (124) comprises one or several axial grooves (see col. 10 lines 47-55: lines of less thickness around the cross section==grooves).
Therefore, it would have been prima facie obvious for one of ordinary skill in the art before the effective filing date of the claimed invention to modify the reduced thickness portion of the tubular sleeve needle cover disclosed in Jansen to comprise one or several axial grooves as taught by Brunel for the purpose of allowing the tubular sleeve comprising the reduced thickness portion to be fitted easily within the surrounding sheath (see col. 10 lines 50-65), which is advantageous to Jansen’s reduced thickness portion on a needle cover/tubular sleeve 28 housing a syringe 12 and being surrounded by a tubular sheath 26, thus achieving “the one of several axial grooves” of the reduced thickness portion.
Claims 7 and 12 are rejected under 35 U.S.C. 103 as being unpatentable over Jansen as applied to claim 1 above, and further in view of Srinivasan et al. (U.S. Patent No. 9,649,452), hereinafter Srinivasan.
Regarding claim 7, Jansen discloses the safety device of claim 1, but Jansen is silent to “wherein the bump has a cantilevered portion.”
However, Srinivasan teaches a safety device (see FIG. 14 and col 2 lines 50-67) comprising a tubular body (18) and a needle cover (14), wherein the body (18) has a bump (40) and the needle cover (14) has a distal abutment surface (46, see col. 3 lines 1-10: ramped surface 46 on needle carrier 14 and is in sliding engagement with 40. Structure 46 seen in FIG. 8) abutting the bump (40) and wherein the bump (40) has a cantilevered portion (44, see col 2 lines 61-62: cantilevered arm 44).
Therefore, it would have been prima facie obvious for one of ordinary skill in the art before the effective filing date of the claimed invention to modify the bump of the body disclosed in Jansen to include a cantilevered portion as taught by Srinivasan for the purpose of creating a snap-engagement (see col. 2 lines 56-59) that allows the bump to by-pass the abutting surface in a preferred direction while inhibiting movement in the other (see col. 3 lines 1-10), thus achieving “wherein the bump has a cantilevered portion.”
Regarding claim 12, Jansen discloses the safety device of claim 1, and Jansen further discloses wherein the bump (48, see ‘Modified FIG-3’ provided again for reference below)
PNG
media_image7.png
456
729
media_image7.png
Greyscale
of the body (26) has a first end (portion of bump extending in a ‘rightward’/ proximal direction of Fig-3), an opposite second end (portion of bump extending in a ‘leftward’/ distal direction of Fig-3).
Jansen is silent to “a decreasing height from the second end to the first end.”
However, Srinivasan teaches a safety device (see FIG. 14 and col 2 lines 50-67) comprising a tubular body (18) and a needle cover (14), wherein the body (18) has a bump (40), wherein the bump (40) of the body (18) has a first end (see ‘Modified FIG. 11’ below and see assembly of FIG. 13 showing ‘first end’ of bump as shown in ‘Modified FIG. 11’ below as a proximal end side of the bump, similar to the structure as cited for Jansen above),
PNG
media_image8.png
551
582
media_image8.png
Greyscale
an opposite second end (see ‘Modified FIG. 11 above), and a decreasing height from the second end to the first end (see ‘second end height’ greater than ‘first end height’ in ‘Modified FIG.11’ above. Therefore, there is a ‘decreasing height’ from second to first end).
Therefore, it would have been prima facie obvious for one of ordinary skill in the art before the effective filing date of the claimed invention to modify the bump disclosed in Jansen to include a decreasing height from the second to first end as taught by Srinivasan for the purpose of forming the bump with a cantilevered arm structure for creating a snap-engagement (see col. 2 lines 56-59) that allows the bump to by-pass the abutting surface in a preferred direction while inhibiting movement in the other (see col. 3 lines 1-10), thus achieving “a decreasing height from the second end to the first end”.
Claim 10 is rejected under 35 U.S.C. 103 as being unpatentable over Jansen (U.S. Patent No. 6,319,233).
Regarding claim 10, Jansen discloses the safety device of claim 1, and Jansen further discloses wherein the bump (48, see FIG. 1) extends in a circumferential direction (as outlined for each portion of the bump shown below in ‘Modified FIG. 1vi’)
PNG
media_image9.png
473
639
media_image9.png
Greyscale
according to a central angle (see ‘Modified FIG. 1vi’ above), but in the embodiment of FIG.1, Jansen is silent to the central angle “comprised between 22.5°- 45°”.
However, Jansen teaches that the bump is interrupted by the axial slots and therefore the slot size will modify a circumferential length of the bump (see col. 4 lines 56-62). Therefore, a person of ordinary skill in the art would consider the circumferential length of the bump comprising a central angle to be a result effect variable that is optimized through routine experimentation of changing/modifying the size of the first and second axial slot to obtain the circumferential length of the bump such that it comprises a central angle “between 22.5°- 45°”.
Therefore, it would have been obvious to one having ordinary skill in the art at the time of the invention to modify the central angle forming the circumferential length of the bump disclosed in Jansen by modifying the size (such as the width) of each axial slot to obtain a central angle “between 22.5°- 45°” associated with a desired flexibility of the device defined by the slot size (see col 4 lines 45-56) as a matter of routine optimization since it has been held that “where the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation." In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955).
Response to Arguments
Applicant's arguments filed 07/01/26 have been fully considered but they are not persuasive.
On pages 6-7, Applicant argues that the width of the reduced thickness portion disclosed by Jansen is not “less than” a width of the rest of the needle cover and therefore the 35 U.S.C. § 102 claim rejections, such as independent claim 1, under Jansen should be withdrawn. However, the examiner disagrees and has maintained the rejection of claim 1.
As shown in the rejection of claim 1 above, Jansen discloses the cross-sectional width of the reduced thickness portion wall is less than the cross-sectional width of the rest of the needle cover wall (see Modified figures in claim 1 above). Thus, Jansen discloses the limitation at least by the drawings and thus anticipates the claim (see MPEP § 2125.I: “Drawings and pictures can anticipate claims if they clearly show the structure which is claimed. In re Mraz, 455 F.2d 1069, 173 USPQ 25 (CCPA 1972).” And “The drawings must be evaluated for what they reasonably disclose and suggest to one of ordinary skill in the art. In re Aslanian, 590 F.2d 911, 200 USPQ 500 (CCPA 1979).”). Therefore, the examiner was not persuaded by this argument and maintained the 35 U.S.C. § 102 rejection of claim 1.
Because no further arguments were presented, all subsequent depending claim rejections were also maintained by the examiner.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to KATHLEEN PAIGE VOKES whose telephone number is (571)272-0198. The examiner can normally be reached M-F: 730AM-330PM Eastern Time.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Tsai can be reached at (571) 270-5246. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/KATHLEEN PAIGE VOKES/Examiner, Art Unit 3783
/MICHAEL J TSAI/Supervisory Patent Examiner, Art Unit 3783
Prosecution Insights